ArticleJournal of pharmacokinetics and pharmacodynamics2017

Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selection.

Yasunori Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.